🔥 Fat Loss & MetabolismFDA Approved

Semaglutide

Ozempic · Wegovy · GLP-1 Agonist

The breakthrough GLP-1 agonist for sustainable weight loss

Typical Dose

0.5–2.4 mg per week

Route

Subcutaneous

Frequency

Once weekly

Cycle

Ongoing (chronic use)

Semaglutide peptide hero image

Overview

You have almost certainly heard of Semaglutide — it is the active ingredient in Ozempic and Wegovy. It works by mimicking a hormone your gut naturally releases after you eat, called GLP-1. That hormone tells your brain you are full and tells your pancreas to manage blood sugar. Semaglutide does the same thing, but lasts much longer in your body. The result is that people feel full sooner, eat less, and lose significant weight. It is one of the most studied and prescribed medications in the world right now. If you are wondering how it compares to newer options, see our Tirzepatide page (dual GIP/GLP-1) and Retatrutide page (triple receptor) for the full GLP-1 family comparison.

Key Benefits

Significant and sustained weight loss (15–20% body weight)
Reduces appetite and food cravings
Improves blood sugar regulation
Cardiovascular risk reduction
Slows gastric emptying
FDA approved for type 2 diabetes and obesity

Mechanism of Action

Semaglutide activates GLP-1 receptors in three key places. In your brain, it dials down appetite and cravings. In your pancreas, it helps release insulin when blood sugar is high (and stops the hormone that raises blood sugar). In your stomach, it slows down how fast food moves through, which keeps you feeling full longer. All three effects work together to reduce how much you eat and how your body handles the calories you do consume.

Dosing Protocol

Typical Dose

0.5–2.4 mg per week

Dose Range

0.25 mg (starting) to 2.4 mg (maintenance)

Frequency

Once weekly

Route

Subcutaneous injection

Cycle Length

Ongoing (chronic use)

CLINICAL NOTES

Dose is titrated up slowly over 16–20 weeks to minimize GI side effects. Must be prescribed by a physician.

Save to Library

Reconstitution calculator and cycle planner pre-filled with Semaglutide defaults

Side Effects & Safety

Nausea (very common, especially initially)
Vomiting
Diarrhea or constipation
Potential pancreatitis (rare)
Thyroid C-cell tumors (theoretical, based on animal studies)

IMPORTANT DISCLAIMER

This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol. Individual responses vary and medical supervision is recommended.

Research References

Common Stacks

GLP-1 agents are typically run solo or with metabolic support peptides. Avoid stacking with other appetite suppressants.

Frequently Asked Questions

Quick Reference

CategoryFat Loss & Metabolism
Research StatusFDA Approved
Typical Dose0.5–2.4 mg per week
RouteSubcutaneous
CycleOngoing (chronic use)
Opens a print dialog. Choose Save as PDF as the destination to download a clean one-page PDF.

Community Reviews

Real experiences from the Peptide Insights community

Have you used Semaglutide?

Real experiences from real people help others make informed decisions. Share what worked, what didn't, and what you wish you'd known before starting.

Dosing insightsResults timelineSide effectsStack combinations
Sign In to Share Your Experience

Free account required. Your review helps the Peptide Insights community.

No reviews yet for Semaglutide

Be the first to share your experience. Your insight could help someone else decide if Semaglutide is right for them.

Sign In to Be the First
Free Guide

Want to go deeper on Semaglutide?

Get our free 32-page Beginner's Guide — plain-language breakdowns of the top peptides, dosing essentials, and safety basics.

Free Beginner's Guide

32-page PDF, instant download

No spam. Unsubscribe anytime.